
Non-vascular Stent Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Description
Non-vascular Stents Market Summary
Introduction
Non-vascular stents are medical devices used to maintain patency in non-vascular bodily conduits, addressing conditions like lung cancer (2.38 million new cases annually), COPD (300 million cases), and gastrointestinal or urological disorders. The market is driven by rising chronic disease prevalence, an aging population (2.1 billion over 60 by 2050), and a shift toward minimally invasive techniques that reduce hospital stays. Innovations such as biodegradable stents and advanced materials like nitinol enhance efficacy. The global market is projected to reach between USD 910 million and USD 1,500 million in 2025, with a CAGR of 3.2% to 5.4% through 2030.
Regional Analysis
North America: The U.S. leads with high chronic disease rates, while Canada focuses on elderly care.
Europe: Germany, France, and the UK drive demand due to advanced healthcare and aging populations.
Asia Pacific: China and India see growth from rising disease burden, while Japan emphasizes precision treatments.
Rest of the World: Brazil expands stenting procedures, and the Middle East invests in medical advancements.
Application Analysis
Hospitals: Expected growth of 3.0%-5.2%, driven by complex cases. Trends focus on durable stents.
Ambulatory Care Centers (ASCs): Projected growth of 3.4%-5.6%, linked to outpatient procedures. Developments emphasize quick deployment.
Specialty Clinics: Anticipated growth of 3.2%-5.4%, suited for targeted treatments. Advances prioritize patient comfort.
Type Analysis
Gastrointestinal Stents: Expected growth of 3.3%-5.5%, valued for digestive relief. Trends highlight biodegradability.
Urological Stents: Projected growth of 3.1%-5.3%, key for urinary flow. Advances focus on comfort.
Pulmonary (Airway) Stents: Anticipated growth of 3.5%-5.7%, driven by lung conditions. Innovations emphasize airway support.
Biliary Stents: Expected growth of 3.0%-5.2%, suited for bile duct issues. Trends lean toward durability.
Others: Projected growth of 2.9%-5.1%, covering niche uses. Advances focus on customization.
Key Market Players
Leading firms include Boston Scientific Corporation, offering airway stents; Medtronic, enhancing stent designs; TAEWOONG, specializing in GI stents; Cook Medical, advancing iCast; CONMED Corporation, supporting endoscopy; Micro-Tech (Nanjing), focusing on digestive stents; ELLA-CS, s.r.o., innovating with biodegradable options; and Merit Medical, targeting non-vascular solutions.
Porter's Five Forces Analysis
Threat of New Entrants: Moderate, due to regulatory and manufacturing barriers, though innovative startups can emerge.
Threat of Substitutes: Low, as non-vascular stents are essential for specific conditions with no direct alternatives.
Bargaining Power of Buyers: Moderate, with facilities seeking effective, affordable stents, though specialized needs limit options.
Bargaining Power of Suppliers: Low, with multiple material suppliers.
Competitive Rivalry: High, with competition on biodegradability, material innovation, and procedure efficiency.
Market Opportunities and Challenges
Opportunities:
Lung cancer (2.38 million cases) and COPD (300 million cases) drive demand.
Aging populations (2.1 billion over 60 by 2050) and injury-related needs boost growth, while biodegradable stents and AI navigation enhance outcomes.
Minimally invasive preferences increase adoption.
Challenges:
High costs of advanced stents limit penetration in low-income regions.
Regulatory delays for new materials slow entry.
Limited specialists in rural areas restrict market reach.
Market News
In January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd., strengthening its GI stent portfolio.
In March 2024, Cook Medical and Getinge signed a distribution contract for the iCast covered stent system in the U.S.
Introduction
Non-vascular stents are medical devices used to maintain patency in non-vascular bodily conduits, addressing conditions like lung cancer (2.38 million new cases annually), COPD (300 million cases), and gastrointestinal or urological disorders. The market is driven by rising chronic disease prevalence, an aging population (2.1 billion over 60 by 2050), and a shift toward minimally invasive techniques that reduce hospital stays. Innovations such as biodegradable stents and advanced materials like nitinol enhance efficacy. The global market is projected to reach between USD 910 million and USD 1,500 million in 2025, with a CAGR of 3.2% to 5.4% through 2030.
Regional Analysis
North America: The U.S. leads with high chronic disease rates, while Canada focuses on elderly care.
Europe: Germany, France, and the UK drive demand due to advanced healthcare and aging populations.
Asia Pacific: China and India see growth from rising disease burden, while Japan emphasizes precision treatments.
Rest of the World: Brazil expands stenting procedures, and the Middle East invests in medical advancements.
Application Analysis
Hospitals: Expected growth of 3.0%-5.2%, driven by complex cases. Trends focus on durable stents.
Ambulatory Care Centers (ASCs): Projected growth of 3.4%-5.6%, linked to outpatient procedures. Developments emphasize quick deployment.
Specialty Clinics: Anticipated growth of 3.2%-5.4%, suited for targeted treatments. Advances prioritize patient comfort.
Type Analysis
Gastrointestinal Stents: Expected growth of 3.3%-5.5%, valued for digestive relief. Trends highlight biodegradability.
Urological Stents: Projected growth of 3.1%-5.3%, key for urinary flow. Advances focus on comfort.
Pulmonary (Airway) Stents: Anticipated growth of 3.5%-5.7%, driven by lung conditions. Innovations emphasize airway support.
Biliary Stents: Expected growth of 3.0%-5.2%, suited for bile duct issues. Trends lean toward durability.
Others: Projected growth of 2.9%-5.1%, covering niche uses. Advances focus on customization.
Key Market Players
Leading firms include Boston Scientific Corporation, offering airway stents; Medtronic, enhancing stent designs; TAEWOONG, specializing in GI stents; Cook Medical, advancing iCast; CONMED Corporation, supporting endoscopy; Micro-Tech (Nanjing), focusing on digestive stents; ELLA-CS, s.r.o., innovating with biodegradable options; and Merit Medical, targeting non-vascular solutions.
Porter's Five Forces Analysis
Threat of New Entrants: Moderate, due to regulatory and manufacturing barriers, though innovative startups can emerge.
Threat of Substitutes: Low, as non-vascular stents are essential for specific conditions with no direct alternatives.
Bargaining Power of Buyers: Moderate, with facilities seeking effective, affordable stents, though specialized needs limit options.
Bargaining Power of Suppliers: Low, with multiple material suppliers.
Competitive Rivalry: High, with competition on biodegradability, material innovation, and procedure efficiency.
Market Opportunities and Challenges
Opportunities:
Lung cancer (2.38 million cases) and COPD (300 million cases) drive demand.
Aging populations (2.1 billion over 60 by 2050) and injury-related needs boost growth, while biodegradable stents and AI navigation enhance outcomes.
Minimally invasive preferences increase adoption.
Challenges:
High costs of advanced stents limit penetration in low-income regions.
Regulatory delays for new materials slow entry.
Limited specialists in rural areas restrict market reach.
Market News
In January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd., strengthening its GI stent portfolio.
In March 2024, Cook Medical and Getinge signed a distribution contract for the iCast covered stent system in the U.S.
Table of Contents
81 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Non-Vascular Stent Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Non-Vascular Stent Market in North America (2020-2030)
- 8.1 Non-Vascular Stent Market Size
- 8.2 Non-Vascular Stent Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Non-Vascular Stent Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Non-Vascular Stent Market in South America (2020-2030)
- 9.1 Non-Vascular Stent Market Size
- 9.2 Non-Vascular Stent Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Non-Vascular Stent Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Non-Vascular Stent Market in Asia & Pacific (2020-2030)
- 10.1 Non-Vascular Stent Market Size
- 10.2 Non-Vascular Stent Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Non-Vascular Stent Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Non-Vascular Stent Market in Europe (2020-2030)
- 11.1 Non-Vascular Stent Market Size
- 11.2 Non-Vascular Stent Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Non-Vascular Stent Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Non-Vascular Stent Market in MEA (2020-2030)
- 12.1 Non-Vascular Stent Market Size
- 12.2 Non-Vascular Stent Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Non-Vascular Stent Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Non-Vascular Stent Market (2020-2025)
- 13.1 Non-Vascular Stent Market Size
- 13.2 Non-Vascular Stent Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Non-Vascular Stent Market Size by Type
- Chapter 14 Global Non-Vascular Stent Market Forecast (2025-2030)
- 14.1 Non-Vascular Stent Market Size Forecast
- 14.2 Non-Vascular Stent Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Non-Vascular Stent Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Boston Scientific Corporation
- 15.1.1 Company Profile
- 15.1.2 Main Business and Non-vascular Stent Information
- 15.1.3 SWOT Analysis of Boston Scientific Corporation
- 15.1.4 Boston Scientific Corporation Non-vascular Stent Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 Medtronic
- 15.2.1 Company Profile
- 15.2.2 Main Business and Non-vascular Stent Information
- 15.2.3 SWOT Analysis of Medtronic
- 15.2.4 Medtronic Non-vascular Stent Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 TAEWOONG
- 15.3.1 Company Profile
- 15.3.2 Main Business and Non-vascular Stent Information
- 15.3.3 SWOT Analysis of TAEWOONG
- 15.3.4 TAEWOONG Non-vascular Stent Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Cook Medical
- 15.4.1 Company Profile
- 15.4.2 Main Business and Non-vascular Stent Information
- 15.4.3 SWOT Analysis of Cook Medical
- 15.4.4 Cook Medical Non-vascular Stent Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 CONMED Corporation
- 15.5.1 Company Profile
- 15.5.2 Main Business and Non-vascular Stent Information
- 15.5.3 SWOT Analysis of CONMED Corporation
- 15.5.4 CONMED Corporation Non-vascular Stent Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Non-Vascular Stent Report
- Table Data Sources of Non-Vascular Stent Report
- Table Major Assumptions of Non-Vascular Stent Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Non-Vascular Stent Picture
- Table Non-Vascular Stent Classification
- Table Non-Vascular Stent Applications
- Table Drivers of Non-Vascular Stent Market
- Table Restraints of Non-Vascular Stent Market
- Table Opportunities of Non-Vascular Stent Market
- Table Threats of Non-Vascular Stent Market
- Table Covid-19 Impact For Non-Vascular Stent Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Non-Vascular Stent
- Table Cost Structure Analysis of Non-Vascular Stent
- Table Key End Users
- Table Latest News of Non-Vascular Stent Market
- Table Merger and Acquisition
- Table Planned/Future Project of Non-Vascular Stent Market
- Table Policy of Non-Vascular Stent Market
- Table 2020-2030 North America Non-Vascular Stent Market Size
- Figure 2020-2030 North America Non-Vascular Stent Market Size and CAGR
- Table 2020-2030 North America Non-Vascular Stent Market Size by Application
- Table 2020-2025 North America Non-Vascular Stent Key Players Revenue
- Table 2020-2025 North America Non-Vascular Stent Key Players Market Share
- Table 2020-2030 North America Non-Vascular Stent Market Size by Type
- Table 2020-2030 United States Non-Vascular Stent Market Size
- Table 2020-2030 Canada Non-Vascular Stent Market Size
- Table 2020-2030 Mexico Non-Vascular Stent Market Size
- Table 2020-2030 South America Non-Vascular Stent Market Size
- Figure 2020-2030 South America Non-Vascular Stent Market Size and CAGR
- Table 2020-2030 South America Non-Vascular Stent Market Size by Application
- Table 2020-2025 South America Non-Vascular Stent Key Players Revenue
- Table 2020-2025 South America Non-Vascular Stent Key Players Market Share
- Table 2020-2030 South America Non-Vascular Stent Market Size by Type
- Table 2020-2030 Brazil Non-Vascular Stent Market Size
- Table 2020-2030 Argentina Non-Vascular Stent Market Size
- Table 2020-2030 Chile Non-Vascular Stent Market Size
- Table 2020-2030 Peru Non-Vascular Stent Market Size
- Table 2020-2030 Asia & Pacific Non-Vascular Stent Market Size
- Figure 2020-2030 Asia & Pacific Non-Vascular Stent Market Size and CAGR
- Table 2020-2030 Asia & Pacific Non-Vascular Stent Market Size by Application
- Table 2020-2025 Asia & Pacific Non-Vascular Stent Key Players Revenue
- Table 2020-2025 Asia & Pacific Non-Vascular Stent Key Players Market Share
- Table 2020-2030 Asia & Pacific Non-Vascular Stent Market Size by Type
- Table 2020-2030 China Non-Vascular Stent Market Size
- Table 2020-2030 India Non-Vascular Stent Market Size
- Table 2020-2030 Japan Non-Vascular Stent Market Size
- Table 2020-2030 South Korea Non-Vascular Stent Market Size
- Table 2020-2030 Southeast Asia Non-Vascular Stent Market Size
- Table 2020-2030 Australia Non-Vascular Stent Market Size
- Table 2020-2030 Europe Non-Vascular Stent Market Size
- Figure 2020-2030 Europe Non-Vascular Stent Market Size and CAGR
- Table 2020-2030 Europe Non-Vascular Stent Market Size by Application
- Table 2020-2025 Europe Non-Vascular Stent Key Players Revenue
- Table 2020-2025 Europe Non-Vascular Stent Key Players Market Share
- Table 2020-2030 Europe Non-Vascular Stent Market Size by Type
- Table 2020-2030 Germany Non-Vascular Stent Market Size
- Table 2020-2030 France Non-Vascular Stent Market Size
- Table 2020-2030 United Kingdom Non-Vascular Stent Market Size
- Table 2020-2030 Italy Non-Vascular Stent Market Size
- Table 2020-2030 Spain Non-Vascular Stent Market Size
- Table 2020-2030 Belgium Non-Vascular Stent Market Size
- Table 2020-2030 Netherlands Non-Vascular Stent Market Size
- Table 2020-2030 Austria Non-Vascular Stent Market Size
- Table 2020-2030 Poland Non-Vascular Stent Market Size
- Table 2020-2030 Russia Non-Vascular Stent Market Size
- Table 2020-2030 MEA Non-Vascular Stent Market Size
- Figure 2020-2030 MEA Non-Vascular Stent Market Size and CAGR
- Table 2020-2030 MEA Non-Vascular Stent Market Size by Application
- Table 2020-2025 MEA Non-Vascular Stent Key Players Revenue
- Table 2020-2025 MEA Non-Vascular Stent Key Players Market Share
- Table 2020-2030 MEA Non-Vascular Stent Market Size by Type
- Table 2020-2030 Egypt Non-Vascular Stent Market Size
- Table 2020-2030 Israel Non-Vascular Stent Market Size
- Table 2020-2030 South Africa Non-Vascular Stent Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Non-Vascular Stent Market Size
- Table 2020-2030 Turkey Non-Vascular Stent Market Size
- Table 2020-2025 Global Non-Vascular Stent Market Size by Region
- Table 2020-2025 Global Non-Vascular Stent Market Size Share by Region
- Table 2020-2025 Global Non-Vascular Stent Market Size by Application
- Table 2020-2025 Global Non-Vascular Stent Market Share by Application
- Table 2020-2025 Global Non-Vascular Stent Key Vendors Revenue
- Figure 2020-2025 Global Non-Vascular Stent Market Size and Growth Rate
- Table 2020-2025 Global Non-Vascular Stent Key Vendors Market Share
- Table 2020-2025 Global Non-Vascular Stent Market Size by Type
- Table 2020-2025 Global Non-Vascular Stent Market Share by Type
- Table 2025-2030 Global Non-Vascular Stent Market Size by Region
- Table 2025-2030 Global Non-Vascular Stent Market Size Share by Region
- Table 2025-2030 Global Non-Vascular Stent Market Size by Application
- Table 2025-2030 Global Non-Vascular Stent Market Share by Application
- Table 2025-2030 Global Non-Vascular Stent Key Vendors Revenue
- Figure 2025-2030 Global Non-Vascular Stent Market Size and Growth Rate
- Table 2025-2030 Global Non-Vascular Stent Key Vendors Market Share
- Table 2025-2030 Global Non-Vascular Stent Market Size by Type
- Table 2025-2030 Non-Vascular Stent Global Market Share by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.